Konstantinos Dodos, Tsampika-Vasileia Kalamara, Petros Papalexis, Dimitrios Ap Keramydas, Effie G Papageorgiou, Vasiliki Epameinondas Georgakopoulou
{"title":"石棉暴露与白血病发病率:系统回顾和荟萃分析。","authors":"Konstantinos Dodos, Tsampika-Vasileia Kalamara, Petros Papalexis, Dimitrios Ap Keramydas, Effie G Papageorgiou, Vasiliki Epameinondas Georgakopoulou","doi":"10.21873/invivo.14072","DOIUrl":null,"url":null,"abstract":"<p><strong>Background/aim: </strong>Asbestos comprises six naturally occurring fibrous minerals known for their health risks, particularly in occupational settings. This systematic review evaluates the association between asbestos exposure and leukemia incidence, synthesizing findings from various studies.</p><p><strong>Materials and methods: </strong>We conducted a comprehensive literature search in PubMed, Cochrane Library, and Web of Science, adhering to PRISMA guidelines. Studies included participants exposed to asbestos compared to matched controls, focusing on leukemia incidence. Data extraction and quality assessment were performed using the Newcastle-Ottawa Scale.</p><p><strong>Results: </strong>A total of 1,751,580 participants were included, with 257,572 (14.7%) exposed to asbestos. The incidence of leukemia varied across studies, ranging from 0.02% to 0.45%. Meta-analysis revealed an overall risk ratio of 1.25 (95% confidence interval=0.81-1.94) with significant heterogeneity (I<sup>2</sup>=86%), indicating no statistically significant difference between exposed and non-exposed cohorts.</p><p><strong>Conclusion: </strong>The findings highlight the complexity of the relationship between asbestos exposure and leukemia, influenced by factors such as exposure type, duration, and confounding variables like smoking. While some studies suggest a potential link, the evidence remains inconclusive, necessitating further research. This review underscores the need for high-quality studies to clarify the association between asbestos and leukemia, informing public health policies to reduce exposure risks and protect vulnerable populations.</p>","PeriodicalId":13364,"journal":{"name":"In vivo","volume":"39 5","pages":"2739-2751"},"PeriodicalIF":1.8000,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12396040/pdf/","citationCount":"0","resultStr":"{\"title\":\"Asbestos Exposure and Leukemia Incidence: A Systematic Review and Meta-analysis.\",\"authors\":\"Konstantinos Dodos, Tsampika-Vasileia Kalamara, Petros Papalexis, Dimitrios Ap Keramydas, Effie G Papageorgiou, Vasiliki Epameinondas Georgakopoulou\",\"doi\":\"10.21873/invivo.14072\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background/aim: </strong>Asbestos comprises six naturally occurring fibrous minerals known for their health risks, particularly in occupational settings. This systematic review evaluates the association between asbestos exposure and leukemia incidence, synthesizing findings from various studies.</p><p><strong>Materials and methods: </strong>We conducted a comprehensive literature search in PubMed, Cochrane Library, and Web of Science, adhering to PRISMA guidelines. Studies included participants exposed to asbestos compared to matched controls, focusing on leukemia incidence. Data extraction and quality assessment were performed using the Newcastle-Ottawa Scale.</p><p><strong>Results: </strong>A total of 1,751,580 participants were included, with 257,572 (14.7%) exposed to asbestos. The incidence of leukemia varied across studies, ranging from 0.02% to 0.45%. Meta-analysis revealed an overall risk ratio of 1.25 (95% confidence interval=0.81-1.94) with significant heterogeneity (I<sup>2</sup>=86%), indicating no statistically significant difference between exposed and non-exposed cohorts.</p><p><strong>Conclusion: </strong>The findings highlight the complexity of the relationship between asbestos exposure and leukemia, influenced by factors such as exposure type, duration, and confounding variables like smoking. While some studies suggest a potential link, the evidence remains inconclusive, necessitating further research. This review underscores the need for high-quality studies to clarify the association between asbestos and leukemia, informing public health policies to reduce exposure risks and protect vulnerable populations.</p>\",\"PeriodicalId\":13364,\"journal\":{\"name\":\"In vivo\",\"volume\":\"39 5\",\"pages\":\"2739-2751\"},\"PeriodicalIF\":1.8000,\"publicationDate\":\"2025-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12396040/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"In vivo\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.21873/invivo.14072\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"MEDICINE, RESEARCH & EXPERIMENTAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"In vivo","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.21873/invivo.14072","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0
摘要
背景/目的:石棉包括六种已知具有健康风险的天然纤维矿物,特别是在职业环境中。本系统综述综合了各种研究结果,评估了石棉暴露与白血病发病率之间的关系。材料和方法:我们在PubMed, Cochrane Library和Web of Science中进行了全面的文献检索,遵循PRISMA指南。研究将暴露于石棉的参与者与匹配的对照组进行比较,重点关注白血病的发病率。使用纽卡斯尔-渥太华量表进行数据提取和质量评估。结果:共纳入1,751,580名参与者,其中257,572人(14.7%)暴露于石棉。白血病的发病率在不同的研究中有所不同,从0.02%到0.45%不等。meta分析显示,总体风险比为1.25(95%可信区间=0.81-1.94),存在显著异质性(I2=86%),暴露组与未暴露组之间无统计学差异。结论:研究结果强调了石棉暴露与白血病之间关系的复杂性,受暴露类型、持续时间和吸烟等混杂变量等因素的影响。虽然一些研究表明两者之间存在潜在的联系,但证据仍然不确凿,需要进一步的研究。本综述强调需要进行高质量的研究,以澄清石棉与白血病之间的关系,为公共卫生政策提供信息,以减少暴露风险并保护弱势群体。
Asbestos Exposure and Leukemia Incidence: A Systematic Review and Meta-analysis.
Background/aim: Asbestos comprises six naturally occurring fibrous minerals known for their health risks, particularly in occupational settings. This systematic review evaluates the association between asbestos exposure and leukemia incidence, synthesizing findings from various studies.
Materials and methods: We conducted a comprehensive literature search in PubMed, Cochrane Library, and Web of Science, adhering to PRISMA guidelines. Studies included participants exposed to asbestos compared to matched controls, focusing on leukemia incidence. Data extraction and quality assessment were performed using the Newcastle-Ottawa Scale.
Results: A total of 1,751,580 participants were included, with 257,572 (14.7%) exposed to asbestos. The incidence of leukemia varied across studies, ranging from 0.02% to 0.45%. Meta-analysis revealed an overall risk ratio of 1.25 (95% confidence interval=0.81-1.94) with significant heterogeneity (I2=86%), indicating no statistically significant difference between exposed and non-exposed cohorts.
Conclusion: The findings highlight the complexity of the relationship between asbestos exposure and leukemia, influenced by factors such as exposure type, duration, and confounding variables like smoking. While some studies suggest a potential link, the evidence remains inconclusive, necessitating further research. This review underscores the need for high-quality studies to clarify the association between asbestos and leukemia, informing public health policies to reduce exposure risks and protect vulnerable populations.
期刊介绍:
IN VIVO is an international peer-reviewed journal designed to bring together original high quality works and reviews on experimental and clinical biomedical research within the frames of physiology, pathology and disease management.
The topics of IN VIVO include: 1. Experimental development and application of new diagnostic and therapeutic procedures; 2. Pharmacological and toxicological evaluation of new drugs, drug combinations and drug delivery systems; 3. Clinical trials; 4. Development and characterization of models of biomedical research; 5. Cancer diagnosis and treatment; 6. Immunotherapy and vaccines; 7. Radiotherapy, Imaging; 8. Tissue engineering, Regenerative medicine; 9. Carcinogenesis.